International Comparisons


A promotional image for the the KFF Health Policy 101 International Comparison of Health Systems chapter

Health Policy 101 is a comprehensive guide covering fundamental aspects of U.S. health policy and programs, including Medicare, Medicaid, the Affordable Care Act, employer-sponsored insurance, the uninsured population, health care costs and affordability, women's health issues, and health care politics. The International Comparison of Health Systems chapter explores the performance of the U.S. health system on a number of cost, outcomes, and quality measures by comparing it with those in similarly large and wealthy OECD nations. It highlights that despite significant spending, Americans have shorter life expectancies and encounter more barriers to health care, influenced by both the health system's structure and broader socioeconomic factors. View the Chapter →


Filter

1 - 10 of 68 Results

  • In 2024, life expectancy in the U.S. reached an all-time high of 79 years but remained years behind the average in comparable countries

    How Does U.S. Life Expectancy Compare to Other Countries?

    Issue Brief

    This chart collection examines how life expectancy in the U.S. compares to that of other similarly large and wealthy countries. Life expectancy at birth in the U.S. increased 0.6 years from 78.4 years in 2023 to 79.0 years in 2024, its highest-ever level. However, the average life expectancy in comparable countries was 82.7 years, about 3.7 years longer than in the U.S., reflecting a persistently wide difference in life expectancy between the U.S. and comparable countries.

  • How Does Health Spending in the U.S. Compare to Other Countries?

    Issue Brief

    This analysis examines how U.S. health spending compares to health spending in other high-income nations. While the U.S. still spends the most in total dollars, eight OECD nations had a higher percentage increase in per-person health spending in 2024.

  • Life Expectancy in the U.S. Has Rebounded to Nearly Pre-Pandemic Levels , but Remains Far Below Peer Countries

    How Does the Quality of the U.S. Health System Compare to Other Countries?

    Feature

    This chart collection compare health outcomes, quality of care, and access to services between the U.S. and peer countries. While inconsistent and imperfect metrics make it difficult to firmly assess system-wide health quality in the U.S., a review of the available data prior to the onset of the COVID-19 pandemic suggests that in most of these measures, the U.S. has lagged behind comparably large and wealthy countries.

  • A promotional image for the the KFF Health Policy 101 International Comparison of Health Systems chapter

    International Comparison of Health Systems

    Feature

    This Health Policy 101 chapter explores the performance of the U.S. health system on a number of cost, outcomes, and quality measures by comparing it with those in similarly large and wealthy OECD nations. It highlights that despite significant spending, Americans have shorter life expectancies and encounter more barriers to health care, influenced by both the health system's structure and broader socioeconomic factors.

  • Poll: Two Thirds Believe Dissolving USAID Will Lead to More Illness and Death Globally, While Nearly Half Say It Would Significantly Reduce the Budget Deficit and Fund Domestic Programs

    News Release

    As the Trump administration works to dissolve the U.S. Agency for International Development (USAID), a new KFF poll finds that two-thirds (67%) of the public believe these actions will increase illness and death in low-income countries, and a similar majority (62%) believe it will result in more humanitarian crises around the world.

  • What Drives Differences in Life Expectancy between the U.S. and Comparable Countries?

    Issue Brief

    This analysis compares 2021 data about deaths in the U.S. and 11 other large, wealthy countries by age and cause to understand the primary drivers of the longevity gap between the U.S. and the comparable countries. It finds that the primary reasons for the gap in 2021 were chronic disease, COVID-19 and substance use disorders.

  • How Medicare Negotiated Drug Prices Compare to Other Countries

    Issue Brief

    This analysis finds that Medicare's negotiated prices for 10 high-expenditure prescription drugs are lower than what private Medicare drug plans had been paying, but still much higher than the prices available in 11 other wealthy nations.. It is available on the Peterson-KFF Health System Tracker.

  • What Drives Health Spending in the U.S. Compared to Other Countries

    Issue Brief

    An updated issue brief looks at the drivers of health spending in the U.S. and key differences between the U.S. and other large, wealthy nations. The analysis finds that people in the U.S. spent $5,683 more per person on health care compared to those in similarly large and wealthy countries.